ALPHA O PEPTIDES AG has a total of 30 patent applications. Its first patent ever was published in 2009. It filed its patents most often in Australia, China and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are PROCKOP DARWIN J, TAPIMMUNE INC and NVENTA BIOPHARMACEUTICALS CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | China | 5 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | WIPO (World Intellectual Property Organization) | 5 | |
#5 | Canada | 4 | |
#6 | United States | 4 | |
#7 | EAPO (Eurasian Patent Organization) | 1 | |
#8 | India | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Burkhard Peter | 29 |
#2 | Kulangara Caroline | 25 |
#3 | Piazza Matteo | 18 |
#4 | Paulillo Sara Maria | 18 |
#5 | Raman Senthil Kumar | 18 |
#6 | Mittelholzer Christian | 6 |
#7 | Peter Burkhard | 1 |
Publication | Filing date | Title |
---|---|---|
AU2018238522A1 | Self-assembling protein nanoparticles with built-in six-helix bundle proteins | |
CN110621340A | Self-assembling protein nanoparticles encapsulating immunostimulatory nucleic acids | |
US2016324958A1 | Flagellin-containing protein nanoparticles as a vaccine platform | |
CN104136454A | Self-assembling peptide nanoparticles as vaccines against infection with norovirus | |
CA2713879A1 | Self-assembling peptide nanoparticles useful as vaccines |